Skip to Main Content

Paper Details

A urine-based DNA methylation assay, ProCUrE, to identify clinically significant prostate cancer.
Clin Epigenetics
23
2018
Author NameAffiliation
Fang ZhaoLunenfeld-Tanenbaum Research Institute
Fang ZhaoUniversity of Toronto
Ekaterina Olkhov-MitselLunenfeld-Tanenbaum Research Institute
Ekaterina Olkhov-MitselUniversity of Toronto
Renu JeyapalaLunenfeld-Tanenbaum Research Institute
Rachel HurstUniversity of East Anglia
Colin S CooperUniversity of East Anglia
Daniel S BrewerUniversity of East Anglia
Daniel S BrewerThe Earlham Institute
Jeremy ClarkUniversity of East Anglia
Neil E FleshnerUniversity Health Network, University of Toronto
Bharati BapatLunenfeld-Tanenbaum Research Institute
Bharati BapatUniversity of Toronto
Bharati BapatUniversity Health Network, University of Toronto
  • 1 - 14

Datasets

Release 1.2